Earnings PreviewLBRX
Short Sellers Circle Ahead of LB Pharmaceuticals' Earnings
LBRX heads into today's print with a sharp build in short positioning — the clearest pre-earnings signal on this name. Short interest has risen aggressively. At nearly 15% of the free float (ORTEX estimates 19.3% on…
1 min read
